Callan Capital LLC Purchases 1,018 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Callan Capital LLC lifted its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 34.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,958 shares of the exchange traded fund’s stock after purchasing an additional 1,018 shares during the quarter. Callan Capital LLC’s holdings in SPDR S&P Biotech ETF were worth $353,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. EPG Wealth Management LLC raised its holdings in shares of SPDR S&P Biotech ETF by 152.7% during the third quarter. EPG Wealth Management LLC now owns 460 shares of the exchange traded fund’s stock worth $34,000 after acquiring an additional 278 shares during the period. Tennessee Valley Asset Management Partners bought a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter worth about $44,000. Wetzel Investment Advisors Inc. bought a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter worth about $45,000. Sheets Smith Wealth Management bought a new stake in shares of SPDR S&P Biotech ETF during the 3rd quarter worth about $55,000. Finally, Life Planning Partners Inc bought a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter worth about $64,000.

SPDR S&P Biotech ETF Trading Up 1.5 %

NYSEARCA XBI traded up $1.27 during trading on Friday, reaching $83.49. The company’s stock had a trading volume of 10,390,133 shares, compared to its average volume of 11,723,970. The firm has a market capitalization of $6.49 billion, a price-to-earnings ratio of 11.47 and a beta of 1.08. SPDR S&P Biotech ETF has a 12 month low of $63.80 and a 12 month high of $103.52. The firm has a 50 day moving average price of $92.69 and a 200 day moving average price of $84.64.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.